Management of Soft Plaque and Possible Ulcer in Descending Aorta
Initial medical therapy with aggressive blood pressure control and pain management is recommended for all patients with penetrating atherosclerotic ulcer (PAU) in the descending thoracic aorta, followed by urgent imaging to confirm diagnosis and risk-stratify for intervention. 1
Immediate Management
All patients require:
- Aggressive blood pressure control targeting systolic BP <120 mmHg to reduce wall stress
- Adequate pain control to achieve hemodynamic targets
- Urgent cross-sectional imaging with contrast-enhanced CT (CCT) or cardiac MRI (CMR) to confirm PAU diagnosis and assess high-risk features 1
The 2024 ESC Guidelines establish this as Class I, Level C recommendation for all PAU patients 1.
Risk Stratification
High-risk imaging features that mandate intervention include:
- PAU width ≥13-20 mm
- PAU depth ≥10 mm
- Growth of width or depth >5 mm/year
- Associated saccular aneurysm
- Increasing pleural effusion
- Symptoms indicating expansion (chest/back pain) 1
Treatment Algorithm
For Uncomplicated Type B PAU (Descending Aorta):
Initial conservative management with careful surveillance is recommended 1. This approach is supported by research showing that many PAUs can be managed expectantly - one study found 89% of intramural hematomas decreased at 1 month and 85% completely resolved at 1 year with medical therapy alone 2.
Follow-up imaging schedule:
- 1 month after diagnosis
- Every 6 months thereafter if stable 1
Indications for Intervention:
TEVAR (thoracic endovascular aortic repair) is recommended as first-line therapy for:
- Complicated PAU (rupture, rapid expansion, persistent pain despite medical therapy) - Class I recommendation 1
- Uncomplicated PAU with high-risk imaging features - Class IIa recommendation 1
Open surgery may be considered based on anatomy and medical comorbidities, particularly if TEVAR anatomy is unsuitable 1.
Key Clinical Nuances
The evidence shows important divergence in outcomes:
- Medical therapy carries 4% 30-day mortality in stable patients 2
- Surgical intervention carries 21% 30-day mortality 2
- Rupture at presentation is the strongest predictor of medical therapy failure (odds ratio 20.6) 2
Critical pitfall to avoid: Do not rush to surgery for asymptomatic or stable PAUs. Research demonstrates that expectant management is safe in selected cases - one series showed no aortic operations required during median 457-day follow-up in asymptomatic patients 3. The key is distinguishing stable from unstable lesions using the high-risk imaging criteria above.
Special Considerations
For isolated, asymptomatic, small PAUs without high-risk features, conservative management with regular surveillance may be considered (Class IIb) 1. However, maintain high vigilance as PAUs occur predominantly in elderly patients (mean age 72 years) with multiple comorbidities including hypertension (92%), smoking history (77%), and coronary disease (46%) 2.
The descending thoracic aorta is the most common location for PAUs, making your clinical scenario typical for this pathology 1, 4. The "soft plaque" description aligns with the atherosclerotic substrate that characterizes PAU disease.